• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 480983 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414027821 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414027821 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Keryx Biopharmaceuticals Crosses Below its 10-day MA (KERX)

Published on Wed, 04/17/2013 - 11:32
By Peter Chu

Today, shares of Keryx Biopharmaceuticals (NASDAQ:KERX) have fallen below their 10-day MA of $7.75 on a volume of 677K shares. This may provide swing traders with an opportunity for a short position, as such a crossover often suggests lower prices in the near term.

In the past 52 weeks, shares of Keryx Biopharmaceuticals have traded between a low of $1.28 and a high of $9.98 and are now at $7.61, which is 495% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.3% while the 200-day MA has risen 2.5%.

Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development, and commercialization of novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Keryx is developing KRX-101 (sulodexide), a novel first-in-class oral heparinold compound for the treatment of diabetic nephropathy.

Keryx Biopharmaceuticals has overhead space with shares priced $7.61, or 40.8% below the average consensus analyst price target of $12.86. The stock should find initial support at its 50-day moving average (MA) of $7.11 and further support at its 200-day MA of $3.76.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Tesoro: 52-Week High Recently Eclipsed (...

Tesoro (NYSE:TSO) traded at a new 52-week high today of $68.26. This new high was reac ...

Travelers Looks to Continue to Trade Abo...

Shares of Travelers (NYSE:TRV) traded at a new 52-week high today of $96.29. This new ...

Shares of TECO Energy Rise Above Previou...

TECO Energy (NYSE:TE) traded at a new 52-week high today of $19.25. Approximately 2.3 ...

Recent 52-Week High Exceeded in Shares o...

STERIS (NYSE:STE) traded at a new 52-week high today of $58.58. So far today approxima ...

Sovran Self Storage: The Winning Streak ...

Sovran Self Storage (NYSE:SSS) traded at a new 52-week high today of $82.00. So far to ...

Sonic: 52-Week High Recently Eclipsed (S...

Sonic (NASDAQ:SONC) traded at a new 52-week high today of $24.89. Approximately 1.2 mi ...

Snap-On Looks to Continue to Trade Above...

Snap-On (NYSE:SNA) traded at a new 52-week high today of $128.65. Approximately 354,00 ...

Super Micro Computer: The Winning Streak...

Shares of Super Micro Computer (NASDAQ:SMCI) traded at a new 52-week high today of $30. ...